-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MIB-626 in Friedreich Ataxia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MIB-626 in Friedreich Ataxia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MIB-626 in Friedreich Ataxia Drug Details: MIB-626 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MIB-626 in Acute Renal Failure (ARF) (Acute Kidney Injury)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MIB-626 in Acute Renal Failure (ARF) (Acute Kidney Injury) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MIB-626 in Acute Renal Failure (ARF)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – KVA-12123 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KVA-12123 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KVA-12123 in Colorectal Cancer Drug Details: KVA-12123 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atropine Sulfate in Myopia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atropine Sulfate in Myopia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Atropine Sulfate in MyopiaDrug Details:Atropine sulfate (SYD-101) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACLX-002 in Refractory Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ACLX-002 in Refractory Acute Myeloid Leukemia Drug Details:ACLX-002 is under development for the treatment of relapsed...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ezabenlimab in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ezabenlimab in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ezabenlimab in Laryngeal Cancer Drug Details: Ezabenlimab (BI-754091) is under development for...
-
Product Insights
MIB India Gov – Film and Television Institute of India Campus – Arunachal Pradesh
Equip yourself with the essential tools needed to make informed and profitable decisions with our MIB India Gov - Film and Television Institute of India Campus - Arunachal Pradesh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MIB-626
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry MIB-626 Drug Details MIB-626 is under development for the treatment of muscle endurance, Friedreich's...
-
Sector Analysis
Country Profile: Syrups & Spreads in Romania
The Romanian syrups & spreads sector is led by the ‘Jams, jellies & preserves’ category in both value and volume terms in 2017 and it is also expected to register the fastest value growth during 2017-2022. Hypermarkets & supermarkets is the leading channel for the distribution of syrups & spreads products in the country. Glass is the most commonly used pack material in the sector, while Rigid plastics is forecast to register the fastest growth during 2017-2022. “Hormel Foods Corporation”,...
-
Sector Analysis
Country Profile: Syrups & Spreads in Romania
The Romanian syrups & spreads sector is led by the jams, jellies & preserves category in both value and volume terms in 2018 and the category is also forecast to register the fastest value growth during 2018-2023. Hypermarkets & supermarkets is the leading distribution channel in the country. Glass is the most commonly used pack material, followed by rigid plastics and flexible packaging in 2018. ‘Hormel Foods Corporation, ‘Contec Foods’ and ‘Chipita S.A.’ are the leading players in the Romanian...